|
An Approach to Evaluation of the Effect of
Bioremediation on Biological Activity of Environmental Contaminants:
Dechlorination of Polychlorinated Biphenyls
2/1/2005
Environmental Health
Perspectives
By Steven A. Boyd
The effectiveness of bioremediation efforts is assessed traditionally from
the loss of the chemical of interest. In some cases, analytical techniques are
coupled with evaluation of toxicity to organisms representative of those found
in the affected environment or surrogate organisms. Little is known, however,
about the effect of remediation of environmental chemicals on potential
toxicity to mammalian organisms.
We discuss both an approach that employs mammalian cell system bioassays and
the criteria for selection of the assays. This approach has been used to
evaluate the biological response to mixtures of polychlorinated biphenyls
(PCBs) before and after remediation by reductive dechlorination. The
dechlorination process used results in accumulation of congeners substituted in
only the ortho and para positions and containing fewer chlorines than the
starting mixtures.
Evaluation of the dechlorinated mixture reveals a loss of biological
activity that could be ascribed to coplanar PCBs not containing chlorine in the
ortho positions. Conversely, biological activity associated with
ortho-substituted PCB congeners is unaffected or increased by remediation.
Thus, the results of the bioassays are consistent with the remediation-induced
change in the profile of PCB congeners and the known mechanisms of action of
PCBs. The results emphasize a need for evaluation of the products of
remediation for biological activity in mammalian systems.
Furthermore, the approach outlined demonstrates the potential to assess the
impact of remediation on a range of biological activities in mammalian cells
and thus to estimate positive and negative effects of remediation strategies on
toxicity. Future needs in this area of research include assays to evaluate
biological effects under conditions of exposure that mimic those found in the
environment and models to extrapolate effects to assess risk to people and
wildlife. Key words: bioassay, cytochrome P450, dechlorination, insulin, in
vitro fertilization, neutrophil, PCB, transcription, uterine contraction.
doi:10.1289/ehp.6935 available via http://dx.doi.org/[Online 9 December 2004]
**********
Biological remediation technologies offer the advantage of partial or
complete destruction of contaminants within a site. The ultimate goal of remediation
is conversion of toxic organic contaminants to simple, less-toxic constituents,
although for some chemicals, incomplete conversion occurs and stable
intermediates are formed.
The effectiveness of remediation strategies is traditionally evaluated from
the disappearance of the chemical of interest. This approach does not consider
that end products or intermediates produced during remediation may be toxic.
Furthermore, the potential exists that remediation may result in products for
which the toxic response is greater than for the parent compound or for which
the target of toxicity is different, and these possibilities would not be
detected.
Accordingly, from the standpoint of assessing risk, it is important to
understand the biological activity or toxicity of the end products and stable
intermediates. Thus, the question becomes, Are the products or intermediates of
bioremediation less toxic than the starting materials?
The anticipated answer to this question is yes; however, there is a dearth
of evidence to support this assumption, particularly with respect to effects on
mammalian systems. There are some reports of decreased toxic effects after
remediation of contaminants, using mammalian systems to evaluate toxicity
(Mousa et al. 1996, 1998; Quensen et al. 1998). On the other hand, some
evidence suggests that products formed during remediation or breakdown of
environmental chemicals have greater biological activity than the starting
materials. For example, DDE [1,1-dichloro-2,2-bis (pchlorophenyl)ethylene], a
major environmental transformation product of DDT
[1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane], is a more potent androgen
receptor antagonist than its parent compound (Kelce et al. 1995). In addition,
products of microbial reductive dechlorination of polychlorinated biphenyls
(PCBs) are more effective than parent PCB mixtures at stimulating uterine
contractions in vitro (Bae et al. 2001). Similarly, chemical remediation may
result in products with increased biological activity.
For example, pyrene, a four-ringed polycyclic aromatic hydrocarbon, can be
degraded with ozone. This ozonation results in the formation of at least 10
major products, some of which are more mutagenic than pyrene itself (Sasaki et
al. 1995). The initial products formed from ozonation of a variety of
polycyclic aromatic hydrocarbons in aqueous solution cause greater inhibition
of the ability of mammalian cells to communicate through gap junctions compared
with the parent compounds (Upham et al. 1997; Weis et al. 1998). These reports
emphasize the need for investigators to consider the biological activity not
only of the parent contaminants, but also of their stable transformation
products produced during remediation.
Bioassays Commonly Used to Assess Effectiveness of Remediation
Investigators have not ignored the question of whether loss of biological
activity accompanies remediation. The approaches used include bioassays using
organisms representative of those we expect to find in the affected environment
or surrogate organisms or plants. For example, the survival, growth, and
reproduction of a variety of marine organisms exposed to sediments or soil
collected from contaminated sites before and after remediation have been used
to assess effectiveness of some remediation strategies [Deanovic et al. 1999;
Kemble et al. 2000; McGann et al. 2003; Tabak et al. 2003; U.S. Environmental
Protection Agency (EPA) 1989]. Toxicity to earthworms has been used to evaluate
the effects of methods of removal of contaminants from soil (Chang et al. 1997;
Maenpaa et al. 2002; Saterbak et al. 1999; U.S. EPA 1988). Luminescent
bacterial assays such as the commercially available Microtox assay have also
been used widely (Ahtiainen et al. 2002; Dorn and Salanitro 2000; Frische and
Hoper 2003; Kemble et al. 2000; Layton et al. 1999). This technique is based on
the observation that some bacteria (e.g., Vibrio fischeri) luminesce in
proportion to cellular metabolism; accordingly, toxicity to the microorganisms
is detected as a decrease in the intensity of luminescence. A solid-phase
application of this method offers an advantage in that it permits exposure of
bacteria to sediment-bound contaminants (Kemble et al. 2000). An integrated
approach to ecotoxicologic evaluation involves combinations of these methods
(Frische 2003).
These approaches yield valuable information regarding effectiveness of
remediation and help focus additional remediation strategies. As with all
bioassays, each has advantages and disadvantages, some of which relate to
sensitivity, cost, versatility of application, reliability, rapidity,
reproducibility, and relationship to health risk. A comprehensive discussion of
these is not within the scope of this work. However, none of these bioassays
addresses the potential biological activity of products of remediation in
mammalian systems that may represent more specific and/or integrated functions
relevant to human health. In the remainder of this article, we review an
approach to the evaluation of toxicity of products of remediation in mammalian
systems.
Bioassays Employing Mammalian Cell Systems
The concept that products of remediation may have biological activity in
mammalian systems has not been studied extensively. Investigators associated
with the Michigan State University Superfund Program Project began an effort a
number of years ago as part of a Bioremediation Product Evaluation Core to
address the issue. The working hypothesis was that products of remediation have
different biological activities compared with those of the starting compounds
or mixtures. We developed a list of assays of biological activity that relied
on the strengths and expertise of the toxicologists within the group (Table 1).
Generally, criteria for useful bioassays include sensitivity over a range of
concentrations of test chemical, low rate of false-positive and false-negative
responses, ease and rapidity of the assay, reproducibility of results, and
reasonable cost. How well the end point being measured reflects a biological
response of interest in humans or animals may also be important. For purposes
of using results from an assay for risk assessment, it is helpful to have a
reference value for toxicity, namely, a response known to be associated with
toxicity in whole organisms.
Assays selected for use in the Bioremediation Product Evaluation Core met
many of these criteria. Additional criteria for inclusion in the Core were that
assays were performed routinely within a laboratory and that the expected
results were relatively uncomplicated in interpretation. These latter two
criteria precluded the use of whole-animal studies, so the assays selected
involved in vitro methodology. With this approach, the list developed covers a
variety of cellular functions including intracellular signaling, intercellular
communication, proliferation and cell death, gene expression, measures of
integrated cellular function and integrated tissue function, and aryl
hydrocarbon (Ah) receptor function (important for dioxin-like contaminants)
(Table 1). Accordingly, although the list is not exhaustive, many possible
responses to chemical insult are represented. Additional measures not
represented on this list that would be useful include whole-animal assessments
and assays that measure endocrine disruption, neurotoxicity, genotoxicity, or
mutagenicity.
In evaluating remediation products, we selected specific bioassays for
initial examination on the basis of current knowledge of the mechanism of
action of the parent compound of interest. For example, for dioxin-like
chemicals (e.g., PCBs) one of the first avenues of investigation was the
effects on cytochrome P450 induction based on the known activity of these
compounds to increase cytochrome P4501A. Similarly, for chemicals known to
disrupt intracellular signaling, such as some of the polycyclic aromatic
hydrocarbons (Burdick et al. 2003; Patten Hitt et al. 2002), first priority for
analysis was given to examination of activation of mitogen-activated protein
kinases or alterations in neutrophil function. Initial studies using this approach
were aimed at evaluation of products of bioremediation of PCBs. One promising
remediation technique for PCBs is the removal of chlorines by microorganisms.
We review results of these studies below.
Evaluation of Products of Reductive Dechlorination of PCBs
Polychlorinated biphenyls are among the most widely distributed
environmental contaminants. Commercial PCB mixtures were manufactured in the United States
between 1929 and 1978 and used for a variety of industrial purposes. An
estimated 1.4 billion pounds of PCBs have been produced worldwide and
approximately several hundred million pounds have been released into the
environment. Commercial PCBs (e.g., Aroclors) typically consist of 60-90 of the
209 possible congeners, each of which differs in the positions and/or numbers
of chlorines on the biphenyl ring. Several characteristic PCB mixtures differ
in the extent of chlorination and specific congener composition. Common
examples are Aroclors 1242, 1248, and 1254, which contain 42, 48, and 54%
chlorine by weight, respectively. Because of their lipophilic properties, PCBs
tend to accumulate in biological tissue and in environments rich in organic
matter, such as sediments.
PCB mixtures found in the environment often do not match any of the known
commercial formulations because they have been subjected to congener-selective
environmental processes, for example, reductive dechlorination by anaerobic
bacteria (Bedard and Quensen 1995; Quensen et al. 1988, 1990). Reductive
dechlorination is a microbially mediated process that removes chlorine from
biphenyl with replacement by hydrogen, resulting in a product mixture in which
the average number of chlorines is substantially diminished. Chlorines
substituted in the meta and para positions are preferentially removed by this
process; ortho chlorines are rarely removed. In situ reductive dechlorination
has been documented in anaerobic sediments at numerous locations, and six
distinct dechlorination patterns have been observed, giving rise to six
recognizable profiles of congeners in the dechlorination products (Bedard and
Quensen 1995).
As mentioned above, PCBs comprise 209 individual congeners, and a variety of
toxic effects mediated by multiple mechanisms accompany this structural
diversity. Effects include neurotoxicity, induction of enzymes involved in
xenobiotic metabolism, alterations in reproductive function, hepatotoxicity,
carcinogenicity, and effects on cells that mediate innate and specific immunity
(Safe 1994). In applying Occam's Razor, one can think of PCBs as falling into
two groups in terms of structure and mechanisms of action (Figure 1). Coplanar
PCBs lack ortho substitution, bind with high affinity to the Ah receptor, and
mediate many of their effects through changes in gene expression initiated by binding
to this receptor. Noncoplanar PCBs, which contain chlorine in one or more of
the four ortho positions, are poor ligands for the Ah receptor. The mechanisms
of their biological effects are in many cases unknown but often involve initial
changes in cell signaling (Fischer et al. 1998).
[FIGURE 1 OMITTED]
Studies were undertaken to compare the biological activity of Aroclor
mixtures of PCBs with the activity of products of their reductive
dechlorination. The dechlorination process employed resulted in accumulation of
congeners substituted in only the ortho and para positions and containing fewer
chlorines than the starting mixtures (Mousa et al. 1996; Quensen et al. 1998).
For example, 2,2',4-trichlorobiphenyl represented 4% (on a molar basis) of the total
mixture before dechlorination and 16% of the dechlorinated product. For more
detailed description of the congener profile of the remediation products, the
reader is referred to Bae et al. (2001), Ganey et al. (2000), and Mousa et al.
(1998).
Table 2 is a summary of the results of examination of biological activity.
Coplanar, dioxin-like PCBs induce cytochrome P4501A through an Ah
receptor-mediated mechanism (Sanderson et al. 1996), and the potency for this
effect can be compared with the potency of dioxin
(2,3,7,8-tetrachlorodibenzo-p-dioxin) to generate a toxic equivalency factor
(TEF) for individual congeners (Safe 1993). TEF values can then be used to
determine the toxic equivalents (TEQs) for mixtures of chemicals. This approach
has been used for risk assessment of dioxin-like compounds, although it is not
without limitation (Li and Hansen 1996; Safe 1998). The ability of products of
dechlorination of Aroclor mixtures to induce cytochrome P4501A activity,
monitored as ethoxyresorufin-O-deethylase activity, was examined in the rat
liver hepatoma cell line H4IIE. Parent Aroclors 1242 and 1254 were compared
with products of their dechlorination by microorganisms collected from two
different sites, Silver Lake, Massachusetts,
and River Raisin, Michigan.
Aroclors were evaluated at concentrations ranging from 0.04 to 2.5
[micro]g/well (250 [micro]L/well), and the dechlorination products were used at
molar equivalent concentrations based on biphenyl concentration (biphenyl
concentration is unaffected by dechlorination). Both potency and efficacy of
induction of the Aroclor mixtures were diminished by dechlorination (Mousa et
al. 1998; Quensen et al. 1998). The decrease in potency was dependent on the
extent of removal of the coplanar and mono-ortho-substituted PCBs, consistent
with the known mechanism of this effect. For example, the TEQ for
nondechlorinated Aroclor 1242 derived from the assay was 3.1, whereas the TEQ
for the dechlorinated mixture was below the limit of detection (0.06). These
values were in agreement with TEQs calculated from the known composition of the
nondechlorinated and dechlorinated mixtures, 5.7 and < 0.08, respectively.
In vitro fertilization is reflective of reproductive capacity. Epidemiologic
studies assessing the effects of human exposure to PCBs on fertility and
reproduction have yielded various results: some indicate a negative effect of
PCBs on fertility, whereas others report no association (Axmon et al. 2001,
2002; Dallinga et al. 2002; Rozati et al. 2002; Yu et al. 2000). In
experimental animals dioxin-like chemicals, including some PCBs, cause
reproductive toxicity (Birnbaum and Tuomisto 2000; Peterson et al. 1993;
Petroff et al. 2001). For example, administration of heavily chlorinated,
noncoplanar PCB congeners to male rats decreases several markers of sperm
function (Hsu et al. 2003). Exposure of female mice to the coplanar congener
3,3',4,4'-tetrachlorobiphenyl decreases reproductive capacity (Huang et al.
1998a), and exposure of pregnant mice to Aroclor 1242 or to 3,3',4,4'-tetrachlorobiphenyl
alters fertility in male offspring (Fielden et al. 2001; Huang et al. 1998b).
In addition, coplanar PCBs inhibit in vitro fertilization of murine eggs (Huang
et al. 1998a). Products of dechlorination of Aroclors 1242 and 1254 were compared
with the parent Aroclors for the ability to inhibit in vitro fertilization of
mouse gametes (Mousa et al. 1996, 1998). Aroclor 1254 decreased the percentage
of fertilized eggs and increased the percentage of degenerated eggs at 10 ppm
and 20 ppm. The products of reductive dechlorination used at equivalent molar
concentrations produced less of an adverse effect on fertilization and did not
cause gamete degeneration. Similarly, the negative effects of Aroclor 1242 on
fertilization were not observed with its product of dechlorination. Based on
the observations that coplanar PCBs and heavily chlorinated, noncoplanar PCBs
alter reproductive capacity, this result was consistent with the loss of these
congeners due to dechlorination.
Environmental exposure to PCBs has been associated with increased risk of
cancer in some but not all studies (Demers et al. 2002; Gammon et al. 2002;
Kimbrough et al. 2003; Laden et al. 2002; Lucena et al. 2001; Stellman et al.
2000; Woolcott et al. 2001). The transcription factor activator protein-1
(AP-1) is a protein that regulates gene expression and has been implicated in
tumori-genesis. Using the rat liver epithelial cell line WB-344, transfected
with AP-l-binding DNA and a luciferase reporter gene, the ability of remediation
products of Aroclors to induce AP-1 activity was determined. Native Aroclors (2
[micro]g/mL) caused a 2- to 3-fold increase in induction of AP-1 transcription,
whereas dechlorinated products (equivalent molar concentration) had no effect
on AP-1-mediated transcription (Mousa et al. 1998). Stimulation of AP-
1-mediated transcription is attributed to more heavily chlorinated, noncoplanar
PCBs; thus, these results are consistent with the loss of heavily chlorinated
congeners upon dechlorination.
Exposure to PCBs has been associated with decreased gestation length in
several epidemiologic studies (Bercovici et al. 1983; Taylor et al. 1989;
Wassermann et al. 1982). Because uterine contractions actuate parturition, the
effects of PCBs on contractility of pregnant rat uteri were examined. Aroclor
1242 stimulated contraction of uteri isolated from pregnant rats in a
concentration- and time-dependent manner (Bae et al. 1999, 2001). A
concentration of 100 [micro]M nondechlorinated Aroclor 1242 increased contraction
frequency, whereas smaller concentrations were without effect (Bae et al.
2001). The potency of various Aroclor mixtures to increase uterine contraction
frequency was inversely related to chlorine content, suggesting that this
effect was mediated by less heavily chlorinated congeners. Results with native
Aroclors were compared with the effects of Aroclors that had been dechlorinated
by microorganisms collected from the Hudson
River basin. Compared
with the response to unaltered Aroclor 1242, the dechlorinated mixture shifted
the concentration--response curve to the left, such that 10 [micro]M of the
dechlorinated mixture caused an increase in uterine contraction frequency.
Similarly, the cumulative concentration--response curve of the dechlorinated
Aroclor 1254 was shifted to the left relative to that of the unaltered Aroclor
1254. In fact, parent Aroclor 1254 did not stimulate contractions with exposure
up to 300 [micro]M, yet the dechlorinated mixture exerted a powerful
stimulatory response in terms of both effective concentration range (30
[micro]M increased contraction frequency) and efficacy. Thus, dechlorination
produced a mixture with uterine-stimulating activity from a relatively
nonactive Aroclor mixture.
PCB exposure has been associated with alterations in immune status in humans
(Belles-Isles et al. 2002; Van Den Heuvel et al. 2002) and experimental animals
(Arena et al. 2003; De Krey and Kerkvliet 1995; De Krey et al. 1994). In
addition, cells of both specific (e.g., lymphocytes) and innate (e.g.,
neutrophils) immunity are affected by PCBs (Fernlof et al. 1997; Ganey et al.
1993; Suh et at. 2003). For example, noncoplanar PCBs stimulate neutrophils to
produce reactive oxygen species, specifically superoxide anion (Ganey et al.
1993). In addition, PCBs increase superoxide anion production in response to
subsequent stimulation with phorbol myristate acetate (PMA). The ability of
Aroclor 1242 to cause generation of reactive oxygen species in neutrophils was
compared with the ability of its products of dechlorination by microorganisms
from Silver Lake or River Raisin (Ganey et al.
2000). Exposure of rat neutrophils in vitro to Aroclor 1242 at 10 [micro]g/mL
increased PMA-stimulated superoxide anion generation. Exposure of neutrophils
to products of dechlorination of Aroclor 1242 at equivalent molar
concentrations caused similar increases in superoxide anion production (Ganey
et al. 2000). Accordingly, dechlorination did not diminish the ability of the
mixtures to activate neutrophils. On the other hand, parent Aroclor 1254 did
not increase superoxide anion production in PMA-stimulated neutrophils, but its
dechlorination products did. Thus, like the effects observed for stimulation of
uterine contractility, dechlorination induced biological activity in a
nonactive Aroclor mixture. These results are consistent with the accumulation
of noncoplanar PCBs in the dechlorination products.
Increased incidence of diabetes has been associated with high concentrations
of PCBs or other organochlorine chemicals in serum (Glynn et al. 2003;
Longnecker et al. 2001). In addition, Aroclor mixtures of PCBs stimulate the
release of insulin from the rat clonal cell line RINm5F (Fischer et al. 1996).
This effect is mediated by noncoplanar PCBs (Fischer et al. 1998). RINm5F cells
were exposed to Aroclor 1242 or 1254 (10 [micro]g/mL) or their products of
dechlorination by River Raisin or Silver
Lake microorganisms
(equivalent molar concentrations), and insulin release was examined. Both parent
Aroclor mixtures caused release of insulin within 30 min of exposure. The
magnitude of response to the mixtures of dechlorinated Aroclors was similar or
greater when compared with the nondechlorinated parent mixtures (Ganey et al.
2000). These results are consistent with the observed accumulation of
ortho-substituted, noncoplanar PCBs in the mixtures produced by reductive
dechlorination.
Taken together, these results demonstrate that a variety of responses can be
observed after exposure of mammalian cell systems to products of remediation.
In the case of the studies described above for remediation of PCBs, the
responses followed what would be expected based on structure and known
biological activity of the chemicals. That is, Ah receptor--mediated activities
diminished because of the removal of coplanar congeners via meta and para
dechlorination processes, and biological activities mediated by noncoplanar
PCBs were enhanced or unchanged. These studies were guided by knowledge of some
of the mechanisms of action of PCBs. For remediation processes aimed at
chemicals for which less is known about effects in mammalian systems, studies
similar to those described above may reveal unexpected results.
Summary and Future Needs
Several important aspects of evaluation were not addressed in this series of
experiments. For this specific case of remediation of PCBs, no measure of
neurotoxicity was performed. This is an important deficit because the
neurotoxic effects of PCBs have been demonstrated experimentally and suggested
by results of epidemiologic studies (Schantz et al. 2001, 2003; Seegal 1996).
Because many neurotoxic effects are associated with noncoplanar PCBs (Kodavanti
and Tilson 1997; Wong et al. 2001), one would expect effects of the products of
remediation to be similar or greater than those of the parent Aroclors.
All the assays used were in vitro assays that represent selected functions
that occur within a whole organism. This approach does not address issues of
exposure, including relevant routes of exposure to environmental contaminants
and their remediation products. In addition, the duration of exposure during in
vitro assays is short and does not mimic longer-term, often-repeated exposures
that occur naturally. Issues of bioavailability are not considered when
performing in vitro assays. This includes bioavailability from an environmental
engineering point of view (e.g., how much of the contaminant is not bound to
soil constituents) and from the perspective of toxicology (e.g., how much of
the exposure dose interacts with target tissue). These issues can best be
addressed using whole-organism studies, which, as mentioned above, are costly
and inconvenient. In addition, biologically based toxicokinetic and
toxicodynamic modeling could be used to address issues of extrapolation to
human risk. In the future, approaches to include these considerations must be
developed.
Thus, it should be emphasized that the approach described above to evaluate
effects of products of remediation in a variety of in vitro assays employing
mammalian cells represents a beginning. Using this approach, the biological
activity of remediation products is compared with activity of the parent
compound, such that relative activity is assessed. Although this is a useful
component in determination of the effectiveness of remediation, it stops short
of estimating potential health risk of the remediation products. Comprehensive
evaluation of the biological activity of remediation products will necessitate
far more extensive in vitro and in vivo testing, the use of validated
extrapolation models to assess risk to people and wildlife, and epidemiologic
correlates. It seems unlikely that this type of effort will arise from any
single institution. It is more likely to be achieved through a consortium of
institutions or a government-based testing facility that can amass the
expertise and resources required.
Despite these limitations, several points can be drawn from these
remediation assessment evaluations. First, the overarching message is that it
is important to evaluate the biological activity of products of remediation and
also of stable intermediates produced during remediation. As seen in the series
of experiments presented above, the products of remediation are not necessarily
devoid of biological activity. When compared with the parent compound, activity
of remediation products may be decreased, unchanged, or increased. It is also
possible that biological activity of remediation products may be qualitatively
different from the activity of the starting compound. Furthermore, although not
observed in the studies described above, when bacteria are used in remediation
processes, it is possible that bacterial by-products unrelated to the chemical
contaminant itself are produced that have biological activity in some cellular
systems. Another important point to be made is that a better understanding of
the mechanisms of biological effects of contaminants will permit a more
directed approach to evaluation of the activity of the remediation products.
The selection of bioassays to be used as well as the specific details of
experimental design can be based on known mechanisms of action of the parent
compounds. Finally, knowledge of the spectrum of biological activities
associated with remediated chemicals and their stable intermediates will
provide the basis for more accurate risk assessment and guide remediation needs
and approaches.
REFERENCES
Ahtiainen J, Vale R, Jarvinen M, Joutti A. 2002. Microbial toxicity tests
and chemical analysis as monitoring parameters at composting of
creosote-contaminated soil. Ecotoxicol Environ Saf 53:323-329.
Arena SM, Greeley EH, Halbrook RS, Hansen LG, Segre M. 2003. Biological
effects of gestational and lactational PCB exposure in neonatal and juvenile
C57BL/6 mice. Arch Environ Contam Toxicol 44:272-280.
Axmon A, Rylander L, Stromberg U, Dyremark E, Hagmar L. 2001.
Polychlorinated biphenyls in blood plasma among Swedish female fish consumers
in relation to time to pregnancy. J Toxicol Environ Health A 64:485-498.
Axmon A, Rylander L, Stromberg U, Hagmar L. 2002. Female fertility in
relation to the consumption of fish contaminated with persistent organochlorine
compounds. Scand J Work Environ Health 28:124-1232.
Bae J, Mousa MA, Quensen JR 3rd, Boyd SA, Loch-Caruso R. 2601. Stimulation
of contraction of pregnant rat uterus in vitro by non-dechlorinated and
microbially dechlorinated mixtures of polychlorinated biphenyls. Environ Health
Perspect 109:275-282.
Bae J, Peters-Golden M, Loch-Caruso R. 1999. Stimulation of pregnant rat
uterine contraction by the polychlorinated biphenyl (PCB) mixture Aroclor 1242
may be mediated by arachidonic acid release through activation of phospholipase
A2 enzymes. J Pharmacol Exp Thor 289:1112 1120.
Bedard DL, Quensen JF III. 1995. Microbial reductive dechlorination of
polychlorinated biphenyls. In: Ecological and Applied Microbiology: Microbial
Transformation and Degradation of Toxic Organic Chemicals (Young LY, Cerniglia
CE, eds). New York:Wiley-Liss,
127-216.
Belles-Isles M, Ayotte P, Dewailly E, Weber JP, Roy R. 2002. Cord blood
lymphocyte functions in newborns from a remote maritime population exposed to
organochlorines and methylmercury. J Toxicol Environ Health A 65:165182.
Bercovici B, Wassermann M, Cucos S, Ron M, Wassermann D, Pines A. 1983.
Serum levels of polychlorinated biphenyls and some organochlorine insecticides
in women with recent and former missed abortions. Environ Res 30:169-174.
Birnbaum LS, Tuomisto J. 2000. Non-carcinogenic effects of TCDD in animals.
Food Addit Contam 17:275-288.
Burdick AD, Davis JW 2nd, Liu KF, Hudson LG, Shi H, Monske ML, et al. 2003.
Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen
species, and transactivate the epidermal growth factor receptor in breast epithelial
cells. Cancer Res 63:7825-7833.
Chang LW, Meier JR, Smith MK. 1997. Application of plant and earthworm
bioassays to evaluate remediation of a lead-contaminated soil. Arch Environ
Contam Toxicol 32:166-171.
Dallinga JW, Moonen EJ, Dumoulin JC, Evers JL, Geraedts, JP, Kleinjans JC.
2002. Decreased human semen quality and organochlorine compounds in blood. Hum
Reprod 17:1973-1979.
Deanovic L, Connor VM, Knight AW, Major KJ. 1999. The use of bioassays and
toxicity identification evaluation (TIE) procedures to assess recovery and
effectiveness of remedial activities in a mine drainage-impacted stream system.
Arch Environ Contam Toxicol 36:21-27.
De Krey GK, Baecher-Steppan L, Fowles JR, Kerkvliet NI. 1994.
Polychlorinated biphenyl-induced suppression of cytotoxic T lymphocyte
activity: role of prostaglandin-[E.sub.2]. Toxicol Lett 74:211-220.
De Krey GK, Kerkvliet NI. 1995. Suppression of cytotoxic T lymphocyte
activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in
vitro, and is independent of corticosterone elevation. Toxicology 97:105-112.
Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. 2002. Plasma
concentrations of polychlorinated biphenyls and the risk of breast cancer: a
congener-specific analysis. Am J Epidemiol 155:629-635.
Dorn PB, Salanitro JP. 2000. Temporal ecological assessment of oil
contaminated soils before and after bioremediation. Chemosphere 40:419-426.
Fernlof G, Gadhasson I, Podra K, Darnerud PO,
Thuvander A. 1997. Lack of effects of some individual polybrominated diphenyl
ether (PBDE) and polychlorinated biphenyl (PCB) congeners on human lymphocyte
functions in vitro. Toxicol Lett 90:189-197.
Fielden MR, Halgren RG, Tashiro CH, Yeo BR, Chittim B, Chou K, et al. 2001.
Effects of gestational and lactational exposure to Aroclor 1242 on sperm
quality and in vitro fertility in early adult and middle-aged mice. Reprod
Toxicol 15:281-292.
Fischer LJ, Seegal RF, Ganey PE, Pessah IN, Kodavanti PR. 1998. Symposium
overview: toxicity of non-coplanar PCBs. Toxicol Sci 41:49-61.
Fischer LJ, Zhou H, Wagner MA. 1996. Polychlorinated biphenyls release
insulin from RINm5F cells. Life Sci 59:2041-2049.
Frische T. 2003. Ecotoxicological evaluation of in situ bioremediation of
soils contaminated by the explosive 2,4,6-trinitrotoluene (TNT). Environ Pollut
121:103-113.
Frische T, Hoper H. 2003. Soil microbial parameters and luminescent bacteria
assays as indicators for in situ bioremediation of TNT-contaminated soils.
Chemosphere 50:415-427.
Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL, Britton JA, et al.
2002. Environmental toxins and breast cancer on Long Island. II. Organochlorine
compound levels in blood. Cancer Epidemiol Biomarkers Prev 11:686-697.
Ganey PE, Quensen JF, Mousa MA, Boyd SA, Wagner MA, Fischer LJ. 2000.
Biological activity associated with noncoplanar polychlorinated biphenyls after
microbial dechlorination of Aroclor 1242 and Aroclor 1254. Environ Toxicol Chem
19:1311-1316.
Ganey PE, Sirois JE, Denison M, Robinson JP,
Roth RA. 1993. Neutrophil function after exposure to polychlorinated biphenyls
in vitro. Environ Health Perspect 101:430-434.
Glynn AW, Granath F, Aune M, Atuma S, Darnerud PO, Bjerselius R, et al.
2003. Organochlorines in Swedish women: determinants of serum concentrations.
Environ Health Perspect 111:349-355.
Hsu PC, Li MH, Guo YL. 2003. Postnatal exposure of
2,2",3,3",4,6"-hexachlorobiphenyl and
2,2",3,4",5",6-hexachlorobiphenyl on sperm function and hormone
levels in adult rats. Toxicology 187:117 126.
Huang A, Lin S, Inglis R, Powell D, Chou K. 1998a. Pre- and postnatal
exposure to 3,3",4,4"-tetrachlorobiphenyl. II. Effects on the
reproductive capacity and fertilizing ability of eggs in female mice. Arch
Environ Contam Toxicol 34:209-214.
Huang A, Powell D, Chou K. 1998b. Pre- and postnatal exposure to
3,3",4,4'-tetrachlorobiphenyl. I. Effects on breeding ability and sperm
fertilizing ability in male mice. Arch Environ Contam Toxicol 34:204-208.
Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. 1995.
Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist.
Nature 375:581-585.
Kemble NE, Hardesty DG, Ingersoll CG, Johnson BT, Dwyer FJ, MacDonald DD.
2000. An evaluation of the toxicity of contaminated sediments from Waukegan
Harbor, Illinois, following remediation. Arch Environ Contain Toxicol
39:452-461.
Kimbrough RD, Doemland ML, Mandel JS. 2003. A mortality update of male and
female capacitor workers exposed to polychlorinated biphenyls. J Occup Environ
Med 45:271-282.
Kodavanti PR, Tilson HA. 1997. Structure-activity relationships of
potentially neurotoxic PCB congeners in the rat. Neurotoxicology 18:425-441.
Laden F, Ishibe N, Hankinson SE, Wolff MS, Gertig DM, Hunter D J, et al.
2002. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in
the Nurses' Health Study. Cancer Epidemiol Biomarkers Prey 11: 1569-1565.
Layton AC,
Gregory B, Schultz TW, Savior GS. 1999. Validation of genetically engineered
bioluminescent surfactant resistant bacteria as toxicity assessment tools.
Ecotoxicol Environ Saf 43:222-228.
Li MH, Hansen LG. 1996. Enzyme induction and acute endocrine effects in
prepubertal female rats receiving environmental PCB/PCDF/PCDD mixtures. Environ
Health Perspect 104:712-722.
Longnecker MP, Klebanoff MA, Brock JW, Zhou H. 2001. Polychlorinated
biphenyl serum levels in pregnant subjects with diabetes. Diabetes Care
24:1099-1101.
Lucena F, Allam MF, Costabeber IH, Villarejo ML, Navajas RF. 2001. Breast
cancer risk factors: PCB congeners. Eur J Cancer Prey 10:117-119.
Maenpaa KA, Kukkonen JV, Lydy MJ. 2002. Remediation of heavy
metal-contaminated soils using phosphorus: evaluation of bioavailability using
an earthworm bioassay. Arch Environ Contain Toxicol 43:389-398.
McGann M, Alexander CR, Bay SM. 2003. Response of benthic foraminifers to
sewage discharge and remediation in Santa Monica Bay, California. Mar Environ
Res 56:299-342.
Mousa MA, Ganey PE, Quensen JF, Madhukar BV, Chou K, Giesy JP, et al. 1998.
Altered biological activities of commercial polychlorinated biphenyl mixtures
after microbial reductive dechlorination. Environ Health Perspect 106(suppl 6):
1409-1418.
Mousa MA, Quensen JF, Chou K, Boyd SA. 1996. Microbial dechlorination
alleviates inhibitory effects of PCBs on mouse gamete fertilization in vitro.
Environ Sci Technol 30:2087-2092.
Patten Hitt E, DeLong MJ, Merrill AH Jr. 2002. Benzo(a)pyrene activates
extracellular signal-related and p38 mitogen-activated protein kinases in HT29
colon and adenocarcinoma cells: involvement in NAD(P)H:quinone reductase
activity and cell proliferation. Toxicol Appl Pharmacol 183:160-167.
Peterson RE, Theobald HM, Kimmel GL. 1993. Developmental and reproductive
toxicity of dioxins and related compounds: cross-species comparisons. Crit Rev
Toxicol 23:285-335.
Petroff BK, Roby KF, Gao X, Son D, Williams S, Johnson D, et al. 2001. A
review of mechanisms controlling ovulation with implications for the
anovulatory effects of polychlorinated dibenzo-p-dioxins in rodents. Toxicology
158:91-107.
Quensen JF III, Boyd SA, Tiedje JM. 1990. Dechlorination of four commercial
polychlorinated biphenyl mixtures (Aroclors) by anaerobic microorganisms from
sediments. Appl Environ Microbiol 56:2360-2369.
Quensen JF III, Mousa MA, Boyd SA, Sanderson TJ, Froese KL, Giesy JP. 1998.
Reduction of aryl hydrocarbon receptor-mediated activity of polychlorinated
biphenyl mixtures due to anaerobic microbial dechlorination. Environ Toxicol
Chem 17:806-813.
Quensen JF III, Tiedje JM, Boyd SA. 1988. Reductive dechlorination of
polychlorinated biphenyls by anaerobic microorganisms from sediments. Science
242:752-754.
Rozati R, Reddy PP, Reddanna P, Mujtaba R. 2002. Role of environmental
estrogens in the deterioration of male factor fertility. Fertil Steril 78:1187-1194.
Safe S. 1993. Development of bioassays and approaches for the risk
assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds.
Environ Health Perspect 101(suppl 3): 317-325.
Safe SH. 1994. Polychlorinated biphenyls (PCBs): environmental impact,
biochemical and toxic responses, and implications for risk assessment. Crit Rev
Toxicol 24:87-149.
Safe SH. 1998. Development validation and problems with the toxic
equivalency factor approach for risk assessment of dioxins and related compounds.
J Anita Sci 76:134-141.
Sanderson JT, Aarts JM, Brouwer A, Froeso KL, Denison MS, Giesy JP. 1996.
Comparison of Ah receptor-mediated luciferase and ethoxyresorufin-O-deethylase
induction in H4IIE cells: implications for their use as bioanalytical tools for
the detection of polyhalogenated aromatic hydrocarbons. Toxicol Appl Pharmacol
137:316-325.
Sasaki J, Arey J, Harper W. 1995. Formation of mutagens from the
photooxidations of 2-4 ring-PAH. Environ Sci Technol 29:1324-1335.
Saterbak A, Toy RJ, Wong DCL, McMain BJ, Williams MP, Dorn PB, et al. 1999.
Ecotoxicological and analytical assessment of hydrocarbon-contaminated soils
and application to ecological risk assessment. Environ Toxicol Chem
18:1591-1607.
Schantz SL, Gasier BM, Polverejan E, McCaffrey RJ, Sweeney AM, Humphrey HE,
et al. 2001. Impairments of memory and learning in older adults exposed to
polychlorinated biphenyls via consumption of Great Lakes
fish. Environ Health Perspect 109:605-611.
Schantz SL, Widholm JJ, Rice DC. 2003. Effects of PCB exposure on
neuropsychological function in children, Environ Health Perspect 111:357-376.
Seegal RF. 1996. Epidemiological and laboratory evidence of PCB-induced
neurotoxicity. Crit Rev Toxicol 28:709-737.
Stellman SD, Djordjevic MV, Britton JA, Muscat
JE, Citron ML, Kemeny M, et al. 2090. Breast cancer risk in relation to adipose
concentrations of organochlorine pesticides and polychlorinated biphenyls in
Long Island, New York. Cancer Epidemiol Biomarkers Prev 9:1241-1249.
Suh J, Kang JS, Yang KH, Kaminski NE. 2003. Antagonism of aryl hydrocarbon
receptor-dependent induction of CYP1A1 and inhibition of IgM expression by
di-ortho-substituted polychlorinated biphenyls. Toxicol Appl Pharmacol
187:11-21.
Tabak HH, Lazorchak JM, Lei L, Khodadouat AP, Antia JE, Bagchi R, et al.
2003. Studies on bioremediation of polycyclic aromatic hydrocarbon-contaminated
sediments: bioavailability, biodegradability, and toxicity issues. Environ
Toxicol Chem 22:473-482.
Taylor PR,
Stelma JM, Lawrence CE. 1989. The relation of polychlorinated biphenyls to
birth weight and gestational age in the offspring of occupationally exposed
mothers. Am J Epidemiol 129:395-406.
Upham BL, Boddy B, Xing XS, Trosko JE, Maaten SJ. 1997. Non-genotoxic
effects of selected pesticides and their disinfection by-products on gap
junctional intercellular communication. Ozone Sci Eng 19:351-489.
U.S.
EPA. 1988. Protocols for Short-term Toxicity Screening of Hazardous Waste
Sites. EPA 600-3-88-029. Corvallis, OR: U.S.
Environmental Protection Agency, Environmental Research Laboratory, Office of
Research and Development.
U.S.
EPA. 1989. Short-term Methods for Estimating Chronic Toxicity of Effluents and
Receiving Waters to Freshwater Organisms, 2nd ed. EPA/600/4-89/001. Cincinnati, OH:U.S. Environmental
Protection Agency, Environmental Monitoring Systems Laboratory.
Van Den Heuvel RL, Koppen G, Staessen JA, Hond ED, Verheyen G, Nawrot TS, et
al. 2902. Immunologic biomarkers in relation to exposure markers of PCBs and
dioxins in Flemish adolescents (Belgium). Environ Health Perspect 110: 595-600.
Wassermann M, Ron M, Bercovici B, Wassermann D, Cucos S, Pines A. 1982.
Premature delivery and organochlorine compounds: polychlorinated biphenyls and
some organochlorine insecticides. Environ Res 28:106-112.
Weis LM, Rummel AM, Masten SJ, Trosko JE, Upham BL. 1998. Bay or bay-like
regions of polycyclic aromatic hydrocarbons were potent inhibitors of gap
junction intercellular communication. Environ Health Perspect 106:17-22.
Wong PW, Garcia EF, Pessah IN. 2001. ortho-Substituted PCB95 alters
intracellular calcium signaling and causes cellular acidification in PC12 cells
by an immunophilin-dependent mechanism. J Neurochem 76:450-463.
Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE,
etal. 2001. Organochlorines and breast cancer risk by receptor status, tumor
size, and grade (Canada).
Cancer Causes Control 12:395-404.
Yu ML, Guo YL, Hsu CC, Rogan WJ. 2009. Menstruation and reproduction in
women with polychlorinated biphenyl (PCB) poisoning: long-term follow-up
interviews of the women from the Taiwan Yucheng cohort. Int J Epidemiol
29:672-677.
This article is based on a presentation at the conference
"Bioremediation and Biodegradation: Current Advances in Reducing Toxicity,
Exposure and Environmental Consequences"
(http://www-apps.niehs.nih.gov/sbrp/ bioremediation.html) held 9-12 June 2002
in Pacific Grove, California, and sponsored by the National Institute of
Environmental Health Sciences (NIEHS) Superfund Basic Research Program. The
overall focus of this conference was on exploring the research interfaces of
toxicity reduction, exposure assessment, and evaluation of environmental
consequences in the context of using state-of-the art approaches to
bioremediation and biodegradation. The Superfund Basic Research Program has a
legacy of supporting research conferences designed to integrate the broad
spectrum of disciplines related to hazardous substances.
Patricia E. Ganey (1) and Steven A. Boyd (2)
Departments of (1) Pharmacology and Toxicology, and (2) Crop and Soil
Science, Institute of Environmental Toxicology, Michigan
State University,
East Lansing, Michigan, USA
Address correspondence to P.E. Ganey, Department of Pharmacology and
Toxicology, 214 Food Safety and Toxicology Building,
Michigan State University, East Lansing, MI 48824 USA.
Telephone: (517) 432-1761. Fax: (517) 432-2310.
This work was supported by grant ES04911 from the National Institutes of
Health.
The authors declare they have no competing financial interests.
Received 23 December 2003; accepted 19 May 2004.
Table 1. Examples of assays used to assess the biological
activity of remediation products.
Assay Biological functions represented
Induction of cytochrome P450
enzymes Receptor-mediated activity
(Ah receptor)
Activation of mitogen-activated
protein kinases Intracellular signaling
Disruption of gap junctional
intercellular communication Intercellular signaling, cell death
Activation of AP-1 transcription
factor Gene expression
Alteration in neutrophil function Cellular function, cell death
Stimulation of insulin release Cellular function
Contraction of uterine muscle in
vitro Integrated tissue function
Alteration in fertilization in
vitro Integrated tissue/organ system
function
Stimulation of lymphocyte Proliferation, cell death
proliferation
Table 2. Summary of effects of biological activity of dechlorinated
PCBs.
Effect of parent Type of PCBs
Biological activity Aroclor mediating effect
Cytochrome Induction Coplanar
P450 activity
In vitro fertilization Reduction Coplanar
AP-1-mediated Induction More heavily chlorinated,
transcription noncoplanar
Uterine Stimulation Less heavily chlorinated,
contraction noncoplanar
Neutrophil Activation Noncoplanar
function
Insulin secretion Stimulation Noncoplanar
Effect of
dechlorinated
Biological activity products Reference
Cytochrome None Mousa et al. 1998,
P450 activity Quensen et al. 1998
In vitro fertilization None Mousa et al. 1996, 1998
AP-1-mediated None Mousa et al. 1998
transcription
Uterine Greater Bae et al. 2001
contraction stimulation
Neutrophil Same or greater Ganey et al. 2000
function activation
Insulin secretion Stimulation Ganey et al. 2000
|